Labs Distribution
Labs Distribution is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 0 yrs |
| Locations | 1 |
| Publications | 1 |
This company is younger than 12 months. There is no public track record yet to base a reliable estimate on, so we'd rather not show a number.
| NACE primary | Wholesale trade(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 17-03-2026 |
| Status | Active |
| Postal code | 1060 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21562A0411/00A002 | Brussels | 2,707 m² | 1 · 2,234 m² | 49.4 m · 10 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
19-03-2026 Incorporation of a new SRL
Technical details
{
"notary": {
"name": "Yorik DESMYTTERE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2026-03-19",
"filing_date": "2026-03-17",
"act_kind_objet": "Objet de l\u0027acte:",
"is_private_deed": false
},
"decision": {
"body": "notarieel_alleen",
"act_date": "2026-03-16",
"unanimous": true
},
"founders": [
{
"org": {
"kbo": "1035.164.501",
"name": "TITHONIA MIDCO 2 LTD",
"address": "1 Duchess Street, Suite 3 Floor 4, Londres, W1W 6AN, Royaume-Uni",
"country": "GB",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e (Angleterre et Pays de Galles)",
"foreign_register_name": "Companies House",
"foreign_register_number": "14460226"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"contribution_type": "geld",
"amount_paid_in_eur": 1.0,
"is_subscriber_only": false,
"n_shares_subscribed": 1,
"amount_subscribed_eur": 1.0,
"is_anonymous_silent_partner": false
}
],
"voorwerp": {
"full_text": "La soci\u00E9t\u00E9 a pour objet, tant en Belgique qu\u0027\u00E0 l\u0027\u00E9tranger, pour elle-m\u00EAme ou pour compte ou en association avec des tiers :\n- Toutes op\u00E9rations ayant trait directement ou indirectement \u00E0 l\u0027achat, la vente, la prise en location, ou l\u0027exploitation sous quelque forme que ce soit, de produits pharmaceutiques. \nLa soci\u00E9t\u00E9 a pour objet la prise en participations dans toutes les soci\u00E9t\u00E9s, sous quelque forme que ce soit, ainsi que la gestion pour son propre compte de ses participations. Elle r\u00E9alise l\u0027exercice de toutes missions d\u0027administration et l\u0027exercice de mandats et de fonctions se rapportant directement ou indirectement \u00E0 son objet. Elle r\u00E9alise la gestion et la valorisation pour son propre compte d\u0027un patrimoine immobilier. \nLa soci\u00E9t\u00E9 a aussi pour objet toutes op\u00E9rations g\u00E9n\u00E9ralement quelconques industrielles, commerciales, financi\u00E8res, mobili\u00E8res ou immobili\u00E8res se rapportant directement ou indirectement \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter directement ou indirectement, partiellement ou totalement la r\u00E9alisation. \nElle peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription au de toute autre mani\u00E8re dans toutes affaires, entreprises, associations ou soci\u00E9t\u00E9s ayant un objet identique, analogue, ou connexe au sien, ou qui sont de nature \u00E0 favoriser le d\u00E9veloppement de son entreprise, \u00E0 lui procurer des mati\u00E8res premi\u00E8res ou \u00E0 faciliter l\u0027\u00E9coulement de ses produits.",
"is_lucrative": true,
"short_summary": "Achat, vente, location et exploitation de produits pharmaceutiques, ainsi que gestion de participations et immobilier."
},
"governance": {
"organ_kind": "raad_van_bestuur",
"n_directors_max": null,
"n_directors_min": 1,
"representation_clause": "chaque administrateur repr\u00E9sente la soci\u00E9t\u00E9 vis-\u00E0-vis de tiers, ainsi qu\u0027en justice",
"co_signature_threshold_eur": null
},
"fiscal_year": {
"end_mm_dd": "09-30",
"start_mm_dd": "10-01",
"first_exercise_end_date": "2026-09-30",
"is_prolonged_first_exercise": false
},
"agm_schedule": {
"time": "10:00",
"month": 2,
"rule_text": "28 du mois de f\u00E9vrier, \u00E0 10 heures"
},
"founding_event": {
"n_shares_total": 1,
"n_share_classes": 1,
"bank_attestation": {
"date": "2026-03-12",
"bank_name": "KBC Bank",
"amount_eur": 1.0,
"iban_masked": null
},
"amount_paid_in_eur": 1.0,
"incorporation_date": "2026-03-16",
"amount_subscribed_eur": 1.0,
"art_5_8_no_payment_due": false,
"pre_incorporation_activity_from_date": null
},
"subject_company": {
"kbo": "1035.621.290",
"email": null,
"region": "brussels_hoofdstedelijk_gewest",
"website": null,
"name_full": "Labs Distribution",
"legal_form": "SRL",
"name_abbreviated": null,
"zetel_address_raw": "1060 Saint-Gilles, Place Marcel Broodthaers 8",
"equity_account_type": "available"
},
"initial_directors": [
{
"kind": "natural_person",
"person": {
"name": "BRYANT Charles Michael",
"address": "1060 Saint-Gilles, Place Marcel Broodthaers 8"
},
"via_org": null,
"role_sub": "administrateur",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
},
{
"kind": "natural_person",
"person": {
"name": "VENNIN Nicolas Michel G\u00E9rard",
"address": "1060 Saint-Gilles, Place Marcel Broodthaers 8"
},
"via_org": null,
"role_sub": "administrateur",
"mandate_until": {
"kind": "indefinite",
"value": null
},
"rep_person_name": null,
"additional_roles": [],
"bestuursverbod_checked": false,
"bestuursverbod_check_date": null,
"rep_prior_publication_ref": null
}
],
"co_filed_documents": [
"expedition",
"statuten",
"volmacht",
"plan financier",
"bankattest"
],
"post_incorporation_mandates": [
{
"kind": "volmacht_kbo",
"holder_org_kbo": "0428.460.282",
"holder_org_name": "VAN BAEL \u0026 BELLIS",
"with_substitution": true,
"holder_person_name": null
},
{
"kind": "volmacht_btw",
"holder_org_kbo": "0428.460.282",
"holder_org_name": "VAN BAEL \u0026 BELLIS",
"with_substitution": true,
"holder_person_name": null
},
{
"kind": "volmacht_publication",
"holder_org_kbo": "0428.460.282",
"holder_org_name": "VAN BAEL \u0026 BELLIS",
"with_substitution": true,
"holder_person_name": null
},
{
"kind": "volmacht_estox",
"holder_org_kbo": "0428.460.282",
"holder_org_name": "VAN BAEL \u0026 BELLIS",
"with_substitution": true,
"holder_person_name": null
},
{
"kind": "volmacht_kbo",
"holder_org_kbo": "0439.814.826",
"holder_org_name": "Grant Thornton Bedrijfsrevisoren",
"with_substitution": true,
"holder_person_name": null
},
{
"kind": "volmacht_publication",
"holder_org_kbo": "0439.814.826",
"holder_org_name": "Grant Thornton Bedrijfsrevisoren",
"with_substitution": true,
"holder_person_name": null
}
]
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameFR | Labs Distribution |